Fibromyalgia Treatment Market - Forecast(2024 - 2030)

Report Code: HCR 1525 Report Format: PDF + Excel

Fibromyalgia Treatment Market Overview:

The Fibromyalgia Treatment Market was valued at 3.200 billion in 2022, and is projected to reach 4.200 billion by 2030, growing at a CAGR of 4% from 2023 to 2030.

The fibromyalgia treatment market was characterized by ongoing research and development efforts to address the complex nature of the condition. Fibromyalgia is a chronic disorder causing widespread musculoskeletal pain, fatigue, and cognitive difficulties. However, there was no specific cure for fibromyalgia, and treatment primarily focused on managing symptoms and improving patients' quality of life.

The market saw a range of pharmaceutical and non-pharmaceutical interventions, including pain medications, antidepressants, and physical therapy. Additionally, alternative therapies such as acupuncture, yoga, and mindfulness techniques gained popularity as complementary treatment options.

The prevalence of fibromyalgia and its impact on patients' lives drove the market's growth, prompting companies and researchers to invest in innovative therapies and better understanding the underlying mechanisms. Nevertheless, a comprehensive and definitive treatment approach remained elusive, and managing fibromyalgia continued to be a multidisciplinary challenge.

Market Snapshot:

Fibromyalgia Treatment Market - Report Coverage:

The “Fibromyalgia Treatment Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Fibromyalgia Treatment Market.



By Type

  • Antidepressants

  • Anticonvulsants

  • Muscle Relaxants

  • Others 

By Distribution

  • Hospital pharmacies

  • Drug stores and retail pharmacies

  • Online providers

By End-user

  • Hospital

  • Clinics

  • Diagnostic Centers

By Diagnosis 

  • Laboratory Evaluation

  • Presence of Central Sensitization

By Treatment 

  • Symptomatic Treatment

  • Targeted Treatment

By Geography

  • North America

  • Europe

  • Asia-Pacific

  • Middle East and Africa

Fibromyalgia Treatment Market - Top Trends:

Personalized Medicine: Researchers were exploring individualized treatment approaches, considering patients' specific symptoms and underlying mechanisms. This approach aimed to improve treatment efficacy and minimize side effects by tailoring therapies to each patient's unique needs.

Non-Pharmacological Therapies: Non-drug treatments like cognitive-behavioral therapy (CBT), physical therapy, and exercise were gaining prominence in fibromyalgia management. These approaches focused on improving patients' coping mechanisms, physical fitness, and overall well-being.

Cannabinoids: There was growing interest in exploring the potential of cannabinoids (e.g., CBD and THC) for pain relief and symptom management in fibromyalgia. However, research was ongoing to understand their safety, efficacy, and long-term effects better.

Virtual Health Solutions: The COVID-19 pandemic accelerated the adoption of telemedicine and virtual health solutions. These technologies facilitated remote consultations, making it more convenient for patients to access specialized care and support.

Research into New Drug Classes: Pharmaceutical companies were investigating novel drug classes targeting specific pathways related to pain processing and neurology. These included NMDA receptor antagonists, serotonin-norepinephrine reuptake inhibitors (SNRIs), and others.

The Fibromyalgia Treatment Market - Company Analysis: 

Pfizer Inc: Pfizer was one of the leading pharmaceutical companies working on fibromyalgia treatments. They developed Lyrica (pregabalin), which is an FDA-approved medication for fibromyalgia pain management.

Eli Lilly and Company: Eli Lilly was actively engaged in research and development efforts to explore potential treatments for fibromyalgia, including new pain medications and biologic therapies.

Teva Pharmaceutical Industries Ltd: Teva was involved in the production of generic medications, including generic versions of drugs used in fibromyalgia treatment, making them more affordable and accessible to patients.

Tonix Pharmaceuticals: Tonix Pharmaceuticals was exploring potential new therapies for fibromyalgia, including TNX-102 SL, a sublingual formulation of cyclobenzaprine.

Aptinyx Inc: Aptinyx was engaged in research and clinical trials to investigate NMDA receptor modulators for the treatment of fibromyalgia.

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the are key strategies adopted by players in the Fibromyalgia Treatment Market Report. The top 10 companies in this industry are listed below:

  1. Sun Pharmaceutical Industries Limited

  2. AbbVie Inc

  3. Lupin Limited

  4. Teva Pharmaceutical Industries Ltd

  5. Viatris Inc

  6. Amneal Pharmaceuticals LLC

  7. Eli Lilly and Company

  8. Novartis AG

  9. Abbott Laboratories

  10. Zydus Lifesciences Limited

Scope of Report: 

Report Metric                           Details

Base Year Considered


Forecast Period

2023 – 2030



Market Size in 2030

4100 million

Segments Covered

By Type, By Distribution, By End user, By Diagnosis, By Treatment, By Geography

Geographies Covered

  • North America

  • Europe

  • Asia-Pacific

  • Middle East and Africa

  • South America

Key Market Players

  1. Sun Pharmaceutical Industries Limited

  2. AbbVie Inc

  3. Lupin Limited

  4. Teva Pharmaceutical Industries Ltd

  5. Viatris Inc

  6. Amneal Pharmaceuticals LLC

  7. Eli Lilly and Company

  8. Novartis AG

  9. Abbott Laboratories

  10. Zydus Lifesciences Limited

For more Lifesciences and Healthcare Market reports, please click here

1. Fibromyalgia Treatment Market - Overview
    1.1. Definitions and Scope
2. Fibromyalgia Treatment Market - Executive Summary
3. Fibromyalgia Treatment Market - Comparative Analysis
    3.1. Company Benchmarking - Key Companies
    3.2. Global Financial Analysis - Key Companies
    3.3. Market Share Analysis - Key Companies
    3.4. Patent Analysis
    3.5. Pricing Analysis
4. Fibromyalgia Treatment Market - Start-up Companies Scenario (Premium)
    4.1. Key Start-up Company Analysis by
        4.1.1. Investment
        4.1.2. Revenue
        4.1.3. Venture Capital and Funding Scenario
5. Fibromyalgia Treatment Market – Market Entry Scenario Premium
    5.1. Regulatory Framework Overview
    5.2. New Business and Ease of Doing Business Index
    5.3. Case Studies of Successful Ventures
6. Fibromyalgia Treatment Market - Forces
    6.1. Market Drivers 
    6.2. Market Constraints
    6.3. Market Challenges
    6.4. Porter's Five Force Model
        6.4.1. Bargaining Power of Suppliers
        6.4.2. Bargaining Powers of Customers
        6.4.3. Threat of New Entrants
        6.4.4. Rivalry Among Existing Players
        6.4.5. Threat of Substitutes
7. Fibromyalgia Treatment Market – Strategic Analysis
    7.1. Value Chain Analysis
    7.2. Opportunities Analysis
    7.3. Market Life Cycle
8. Fibromyalgia Treatment Market – By Type (Market Size – $Million/$Billion) 
        8.1.1. Market Trends by Region
        8.1.2.Market Share & Forecast by Region
        8.2.1. Market Trends by Region
        8.2.2. Market Share & Forecast by Region
        8.3.1. Market Share & Forecast by Region
        8.3.2. Market Share & Forecast by Region
    8.4. ANALGESIC
        8.4.1. Market Share & Forecast by Region
        8.4.2. Market Share & Forecast by Region
    8.5. Others
9. Fibromyalgia Treatment Market – BY DISTRIBUTION (Market Size – $Million/$Billion) 
        9.1.1. Market Trends by Region
        9.1.2. Market Share & Forecast by Region
    9.2. RETAIL PHARMACIES Market Trends by Region
        9.2.1. Market Trends by Region
        9.2.2. Market Share & Forecast by Region
        9.3.1. Market Trends by Region
        9.3.2. Market Share & Forecast by Region
10. Fibromyalgia Treatment Market – By End-User (Market Size – $Million/$Billion) 
    10.1. Hospital
        10.1.1. Market Trends by Region
        10.1.2. Market Share & Forecast by Region
    10.2. Clinics
        10.2.1. Market Trends by Region
        10.2.2 . Market Share & Forecast by Region
    10.3. Diagnostic Censers
        10.3.1. Market Trends by Region
        10.3.2. Market Share & Forecast by Region
11. Fibromyalgia Treatment Market – By Diagnosis (Market Size – $Million/$Billion)
    11.1 Laboratory Evaluation
        11.1.1. Market Trends by Region
        11.1.2. Market Share & Forecast by Region
    11.2 Presence of Central Sensitization
        11.2.1. Market Trends by Region
        11.2.2 . Market Share & Forecast by Region
12. Fibromyalgia Treatment Market – By Treatment (Market Size – $Million/$Billion)
    12.1 Symptomatic Treatment
        12.1.1. Market Trends by Region
        12.1.2. Market Share & Forecast by Region
    12.2. Targeted Treatment
        12.2.1. Market Trends by Region
        12.2.2. Market Share & Forecast by Region
13. Fibromyalgia Treatment Market – by Geography (Market Size – $Million/$Billion) 
    13.1. North America
        13.1.1. The U.S.
        13.1.2. Canada
    13.2. Europe
        13.2.1. UK
        13.2.2. Germany
        13.2.3. France
        13.2.4. Italy
        13.2.5. Spain
        13.2.6. Russia
        13.2.7. Rest of Europe
    13.3. Asia-Pacific
        13.3.1. China
        13.3.2. India
        13.3.3. Japan
        13.3.4. South Korea
        13.3.5. Australia & New Zealand
        13.3.6. Rest of Asia-Pacific
    13.4. South America
        13.4.1. Brazil
        13.4.2. Argentina
        13.4.3. Chile
        13.4.4. Colombia
        13.4.5. Rest of South America
    13.5. Rest of the World
        13.5.1. Middle East
        13.5.2. Africa
14. Fibromyalgia Treatment Market – Entropy
15. Fibromyalgia Treatment Market – Industry/Segment Competition Landscape Premium 
    15.1. Market Share Analysis
        15.1.1. Market Share by Product Type – Key Companies
        15.1.2. Market Share by Region – Key Companies
        15.1.3. Market Share by Country – Key Companies
    15.2. Competition Matrix
    15.3. Best Practices for Companies
16. Fibromyalgia Treatment Market – Key Company List by Country Premium
17. Fibromyalgia Treatment Market - Company Analysis
    17.1. Sun Pharmaceutical Industries Limited
    17.2. AbbVie Inc
    17.3. Lupin Limited
    17.4. Teva Pharmaceutical Industries Ltd
    17.5. Viatris Inc
    17.6. Amneal Pharmaceuticals LLC
    17.7. Eli Lilly and Company
    17.8. Novartis AG
    17.9. Abbott Laboratories
    17.10. Zydus Lifesciences Limited 
    17.13. INTEC PHARMA S.R.O. 
    17.14. APTINYX INC. 
    17.16. ALLEGRAN
    17.17. Innovative Med Concepts
    17.18. Pfizer, Inc 
    17.19. Roche

"Financials to the Private Companies would be provided on best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our 
reports include global-level data, niche markets and competitive landscape.

The Fibromyalgia Treatment Market is projected to grow at 4% CAGR during the forecast period 2023-2030.

Fibromyalgia Treatment Market size is projected to reach 4.100 billion by 2030

Sun Pharmaceutical Industries Limited, AbbVie Inc, Lupin Limited, Teva Pharmaceutical Industries Ltd, Viatris Inc, Amneal Pharmaceuticals LLC, Eli Lilly and Company